Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
ORGO Organogenesis
- 3.700
- +0.020+0.54%
Close Feb 14 16:00 ET
- 3.700
- 0.0000.00%
Post 20:01 ET
465.19MMarket Cap-74.00P/E (TTM)
3.780High3.695Low216.87KVolume3.720Open3.680Pre Close806.99KTurnover0.39%Turnover Ratio92.50P/E (Static)125.73MShares4.57052wk High1.67P/B207.44MFloat Cap2.16552wk Low--Dividend TTM56.06MShs Float310.900Historical High--Div YieldTTM2.31%Amplitude1.795Historical Low3.721Avg Price1Lot Size
About Organogenesis Company
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Company Profile
SymbolORGO
Company NameOrganogenesis
Listing DateDec 2, 2016
Founded1985
CEOMr. Gary S. Gillheeney, Sr
MarketNASDAQ
Employees862
Fiscal Year Ends12-31
Address85 Dan Road
CityCanton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02021
Phone1-781-575-0775
Websitehttp://www.organogenesis.com
Company Executives
- Name
- Position
- Salary
- Gary S. Gillheeney, Sr
- Chairman of the Board, President and Chief Executive Officer
- 6.24M
- Lori Freedman
- Chief Administrative and Legal Officer
- 1.99M
- Brian Grow
- Chief Commercial Officer
- 1.92M
- Patrick Bilbo
- Chief Operating Officer
- 2.16M
- David C. Francisco
- Chief Financial Officer and Principal Accounting Officer
- 1.63M
- Antonio S. Montecalvo
- Vice President, Health Policy
- --
- Robert Cavorsi
- Vice President, Strategy
- --
- David Erani
- Director
- --
- Alan A. Ades
- Director
- --
- Robert Ades
- Director
- --
- Glenn H. Nussdorf
- Director
- --
- Michele Korfin
- Independent Director
- 226.98K
- Jon L. Giacomin
- Independent Director
- 265.00K
- Arthur S. Leibowitz
- Lead Independent Director
- 291.46K
- Gilberto Quintero
- Independent Director
- 226.98K
- Garrett Lustig
- Independent Director
- --
- Prathyusha Duraibabu
- Independent Director
- 240.00K
- Dr. Michael Joseph Driscoll
- Independent Director
- 230.52K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.